BioCentury
ARTICLE | Company News

Advanced Biomedical Systems, Biohit deal

November 25, 2013 8:00 AM UTC

Biohit acquired exclusive, worldwide development and commercialization rights to the UFT300 test for Helicobacter pylori infection from Advanced Biomedical for €350,000 ($472,605). UFT300 detects H. p...